-+ 0.00%
-+ 0.00%
-+ 0.00%

Wells Fargo Maintains Overweight on Axogen, Raises Price Target to $56

Benzinga·10/29/2026 14:07:28
Listen to the news
Wells Fargo analyst Larry Biegelsen maintains Axogen (NASDAQ:AXGN) with a Overweight and raises the price target from $48 to $56.